Welcome to our dedicated page for Teradyne SEC filings (Ticker: TER), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Teradyne, Inc. (NASDAQ: TER) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures filed with the U.S. Securities and Exchange Commission. Teradyne is incorporated in Massachusetts and lists its common stock on the Nasdaq Stock Market LLC under the symbol TER. As a public issuer, it files annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K, along with other required documents. These filings offer detailed information about Teradyne’s automated test equipment and advanced robotics businesses, financial condition, governance, and material corporate events.
Recent Form 8-K filings illustrate the range of topics covered in Teradyne’s current reports. The company files 8-Ks to furnish quarterly earnings press releases under Item 2.02, disclosing results for segments such as Semiconductor Test, Product Test, and Robotics. Other 8-Ks report on executive officer changes, including the appointment of a new Chief Financial Officer, and provide summaries of related compensation and change-of-control arrangements under Item 5.02. Teradyne also uses Form 8-K to disclose director appointments, committee assignments, and amendments to its Amended and Restated By-Laws, including changes to shareholder proposal and director nomination procedures.
Filings related to governance, such as bylaw amendments, describe how Teradyne manages shareholder rights, nomination windows, voting standards, and meeting procedures. These documents help investors understand the company’s corporate governance framework. Additional filings may address material modifications to the rights of security holders, such as changes linked to bylaw updates, and provide timelines for shareholder actions ahead of annual meetings.
On Stock Titan, Teradyne’s SEC filings are presented with AI-powered summaries designed to make complex regulatory documents more accessible. Annual reports (Form 10-K) and quarterly reports (Form 10-Q) can be reviewed with AI-generated highlights that point to key discussions of segment performance, risk factors, and liquidity. Current reports (Form 8-K) are summarized to emphasize the nature of each material event, whether it involves financial results, leadership changes, or governance updates. Investors can also track insider-related filings such as Form 4, where available, to monitor transactions by directors and executive officers. Real-time updates from EDGAR and AI explanations allow users to quickly identify the most relevant information in Teradyne’s filings without reading every page in full.
Teradyne, Inc. (TER) reported insider equity awards to its Chief Financial Officer on 11/03/2025. The filing shows a grant of 11,144 restricted stock units (RSUs) at $0, and a stock option to buy 9,156 shares with a $183.07 exercise price.
The RSUs vest in four equal annual installments beginning on November 3, 2026. The option vests 25% per year over four years beginning on November 3, 2026, and expires on November 3, 2032. Following the transactions, the officer beneficially owned 11,260 shares of common stock directly.
Teradyne, Inc. (TER) reported an initial insider ownership filing. On 11/03/2025, the company’s Chief Financial Officer filed a Form 3, disclosing beneficial ownership of 116 shares of common stock, held directly. No derivative securities were reported. This filing establishes the officer’s baseline holdings under Section 16 reporting rules.
Teradyne filed its Q3 2025 10‑Q, reporting modest revenue growth with lower profitability. For the quarter ended September 28, 2025, total revenues were $769.2 million versus $737.3 million a year ago, driven mainly by Semiconductor Test $440.2 million, Product Test $88.3 million, and Robotics $75.1 million. Asia Pacific accounted for $612.8 million of quarterly revenue. Gross profit was $449.3 million.
Operating income was $145.3 million and net income was $119.6 million (diluted EPS $0.75) compared with $145.6 million (EPS $0.89) last year, reflecting higher operating expenses and a $5.2 million loss from equity in net earnings of affiliate. Year‑to‑date, revenue was $2.11 billion with net income of $296.8 million.
Cash from operations for the nine months was $392.8 million. The company repurchased $523.8 million of stock and paid $57.6 million in dividends ($0.36 per share) year‑to‑date. Cash and cash equivalents were $272.7 million with $200.0 million of short‑term debt. Teradyne completed the $127.2 million acquisition of Quantifi Photonics and a $18.3 million automated test equipment technology acquisition. Unsatisfied performance obligations were $1,744.4 million, with about 89% expected within 12 months.
Teradyne, Inc. filed a current report to note that it has released its financial results for the third quarter ended September 28, 2025. The company issued a press release on October 28, 2025 describing its results of operations and financial condition for that quarter.
The press release is included as Exhibit 99.1 to this report, and the filing also includes the cover page interactive data file as Exhibit 104.
Teradyne (TER) appointed Michelle Turner as Vice President, Chief Financial Officer, and Treasurer, effective November 3, 2025. She will serve as principal financial officer and principal accounting officer. Sanjay Mehta will remain as an executive advisor with compensation unchanged.
Turner’s compensation includes a $640,000 annual base salary and an annual cash incentive bonus with a target equal to 100% of base salary. On November 3, 2025, she will receive an equity award valued at $6,800,000 at target, comprising time-based RSUs, performance-based RSUs, and non-qualified stock options. One-time cash payments include a $200,000 sign-on bonus and $150,000 for relocation.
Her change-of-control agreement provides two years of severance at the annual Model Compensation rate, a prorated target bonus for the year of termination, full accelerated vesting of equity awards (performance awards at target), and two years of continued health, dental, and vision coverage, without a tax gross-up.
Teradyne (TER) reported an insider transaction by its President and CEO (also a Director). On October 10, 2025, the executive sold 1,108 shares of common stock at $145.24 per share. Following the sale, the executive beneficially owns 94,776.995 shares, held directly. The sale was made under a pre‑established Rule 10b5‑1 trading plan adopted on February 4, 2025.
Teradyne, Inc. filing a Form 144 notifies a proposed sale of 1,108 common shares with an aggregate market value of
The shares were acquired on
The notice includes the standard representation that the seller is not aware of undisclosed material adverse information and references Rule 10b5-1 plan language if applicable.
Teradyne director Mercedes Johnson reported a sale of company shares under a pre-set plan and retains significant ownership. The filing shows
Teradyne, Inc. submitted a Form 144 notice for a proposed sale of 625 shares of common stock through Fidelity Brokerage Services LLC with an approximate aggregate market value of
The notice also discloses prior insider sales by Mercedes Johnson of 1,875 shares on
Teradyne director Ernest E. Maddock received deferred stock units (DSUs) on 09/29/2025 under his election to receive dividend equivalents as additional DSUs rather than cash. The filing reports an exempt acquisition under Exchange Act Rule 16b-3(d) with 0 price because DSUs are issued in lieu of cash dividends. Following the transaction, Mr. Maddock beneficially owns 9,593 shares of Teradyne common stock. The DSUs are settled one-for-one into common stock generally within ninety days after the director ceases to serve as a non-employee director.
FAQ
What is the current stock price of Teradyne (TER)?
What is the market cap of Teradyne (TER)?
